QPS, a global contract research organization (CRO) that focuses on bioanalytical products and clinical trials, has partn...
Japanese pharmaceutical company Takeda and US-based Frazier Healthcare Partners have announced a collaboration to l...
German biotech firm BioNTech SE has announced the start of its malaria project which aims at the developm...
ZP Therapeutics, a division of Zuellig Pharma, has announced an official agreement with the Government Pharmaceutical Or...
Universities of Sheffield, Oxford, Liverpool, Newcastle, and Birmingham, with support from the UK Coronavirus Immunology...
US-based Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, has announced...
Shanghai Zerun Biotechnology (ZerunBio) and its parent company Walvax Biotechnology have partnered with Norway-based CEP...
Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) and the International Vaccine Institute (IVI) in Sou...
Commonwealth Scientific and Industrial Research Organisation (CSIRO), based in Australia, played an important role ...
Sinovac Biotech, a leading provider of biopharmaceutical products in China, has received a drug registration approval fr...
The Food and Drug Administration of the Ministry of Health and Welfare in Taiwan has approved the manufacturing of Medig...
Aptamer Group, the UK-based developer of Optimer therapeutics and diagnostics, has secured a contract with a top-five gl...
SINOVAC Biotech, a leading provider of biopharmaceutical products in China, announced that it has signed an advance purc...
An immunology research team at the Korea Advanced Institute of Science and Technology (KAIST) has found that m...
South Korea-based International Vaccine Institute (IVI) and the Kwame Nkrumah University of Science and Technology (KNUS...
DHL Express has delivered the US government's donation of the Pfizer-BioNTech vaccine. The arrival of around 1,000,000 d...
Sanofi will invest approximately €400 million annually in a first-of-its kind vaccines mRNA Center of Excellence. ...
Australian researchers are commencing the first Phase 1 human trial of a COVID-19 gene-based DNA vaccine, delivered via ...
